Showing results (11-20 of 195) with videos related to

Sort By:
Pageof 20
Circulation|July 21, 2016
Management of Bleeding With Non-Vitamin K Antagonist Oral Anticoagulants in the Era of Specific Reversal AgentsChristian T Ruff, Robert P Giugliano, Elliott M Antman
Plos One|March 18, 2021
Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillationKourosh Ravvaz, John A Weissert, Arshad Jahangir, et al.
Current Opinion in Cardiology|August 30, 2019
Cardiovascular risk reduction with icosapent ethylParth N Patel, Siddharth M Patel, Deepak L Bhatt
European Heart Journal. Acute Cardiovascular Care|October 16, 2018
The efficacy and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and coronary artery disease: A meta-analysis of randomized trialsThomas A Zelniker, Christian T Ruff, Elliott M Antman, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 1, 2021
Evaluation of Direct Oral Anticoagulant Prescribing in Patients With Moderate to Severe Renal ImpairmentClara Ting, Megan Rhoten, Jillian Dempsey, et al.
Blood|May 29, 2026
Prior anticoagulation experience and bleeding risk with the factor XI inhibitor abelacimab in AZALEA-TIMI 71Andre Maurice Small, Siddharth M Patel, Robert P Giugliano, et al.
JAMA Cardiology|September 1, 2025
Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical TrialSiddharth M Patel, Robert P Giugliano, David A Morrow, et al.
Circulation. Cardiovascular Genetics|December 15, 2017
Personalized Anticoagulation: Optimizing Warfarin Management Using Genetics and Simulated Clinical TrialsKourosh Ravvaz, John A Weissert, Christian T Ruff, et al.
Journal of the American College of Cardiology|September 4, 2024
Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AFPaul M Haller, Petr Jarolim, Michael G Palazzolo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 19, 2025
Long-term visit-to-visit blood pressure variability and risk of cardiovascular and bleeding events: insights from the ENGAGE AF-TIMI 48 trialRiccardo Proietti, Michael Gerard Palazzolo, Christian T Ruff, et al.
Pageof 20